K201680 is an FDA 510(k) clearance for the NuFACE Mini Plus. Classified as Stimulator, Transcutaneous Electrical, Aesthetic Purposes (product code NFO), Class II - Special Controls.
Submitted by Carole Cole Company (Vista, US). The FDA issued a Cleared decision on February 19, 2021 after a review of 242 days - an extended review cycle.
This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.
Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.
View all Carole Cole Company devices